InvestmentMay 12, 2026, 08:52 AM
Coya Therapeutics to Offer Up to $30M in Common Stock via ATM
AI Summary
Coya Therapeutics, Inc. has entered into a Sales Agreement with Leerink Partners LLC to offer and sell shares of its common stock for aggregate gross proceeds of up to $30,000,000. The sales will be conducted through "at the market" equity offerings on the Nasdaq Capital Market. The company will pay Leerink Partners a 3.0% commission on the gross proceeds from any shares sold.
Key Highlights
- Coya Therapeutics entered a Sales Agreement with Leerink Partners LLC.
- Company may offer and sell up to $30,000,000 of common stock.
- Sales will be made through "at the market" equity offerings.
- Leerink Partners will receive a 3.0% commission on gross proceeds.
- The offering is pursuant to a shelf registration statement on Form S-3.
Price Impact
More from COYA